Oncology Corporate Profile
DNAtrix is a company developing modified oncolytic viruses for the treatment of the most aggressive forms of cancer. Since viruses are already efficient at killing cells, scientists have harnessed this ability by modifying a common cold virus so that it targets and selectively kills cancer cells. DNAtrix is a privately held company with offices located in Houston, Texas and San Diego, California.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|DNX-2401(+ pembrolizumab)||oncolytic virus||Glioblastoma Multiforme (GBM)||II||Merck|
|DNX-2401||oncolytic virus||Glioblastoma Multiforme (GBM)||I|
View additional information on product candidates here »